CME/CE - Global Oncology Academy

Episodes 97-103 of 103

Distinguishing Between High- and Low-Quality RWE: A Journal Club for the Real World
Distinguishing Between High- and Low-Quality RWE: A Journal Club for the Real World
MinuteCE®
Distinguishing Between High- and Low-Quality RWE: A Journal Club for the Real World
0.75 program credits
- Adam Brufsky, MD, PhD
0.75 program credits
MinuteCE®
RWE Where RCTs Fall Short: Optimizing Frontline Treatment of HR+/HER2- Metastatic Breast Cancer
0.75 credits 7 episodes
- Adam Brufsky, MD, PhD
- Christopher M. Gallagher, MD
0.75 credits 7 episodes
Balancing the Scales: The Complementary Roles of RCTs and RWE in Modern Healthcare
Balancing the Scales: The Complementary Roles of RCTs and RWE in Modern Healthcare
MinuteCE®
Balancing the Scales: The Complementary Roles of RCTs and RWE in Modern Healthcare
0.75 program credits
- Christopher M. Gallagher, MD
0.75 program credits
Real World Evidence To Expand Knowledge of CDK4/6 Inhibitor-Related Adverse Effects
Real World Evidence To Expand Knowledge of CDK4/6 Inhibitor-Related Adverse Effects
MinuteCE®
Real World Evidence To Expand Knowledge of CDK4/6 Inhibitor-Related Adverse Effects
0.75 program credits
- Christopher M. Gallagher, MD
- Adam Brufsky, MD, PhD
0.75 program credits
Importance of the Patient Perspective on RWE in Formulating SDM Conversations
Importance of the Patient Perspective on RWE in Formulating SDM Conversations
MinuteCE®
Importance of the Patient Perspective on RWE in Formulating SDM Conversations
0.75 program credits
- Adam Brufsky, MD, PhD
- Christopher M. Gallagher, MD
0.75 program credits
Employing Immunotherapy and ADCs in Advanced Endometrial and Cervical Cancers: Current and Emerging Therapies
Employing Immunotherapy and ADCs in Advanced Endometrial and Cervical Cancers: Current and Emerging Therapies
CME/CE
Employing Immunotherapy and ADCs in Advanced Endometrial and Cervical Cancers: Current and Emerging Therapies
- Robert L. Coleman, MD, FACOG, FACS
- Susana Campos, MD, MPH
- Domenica Lorusso, MD, PhD
TROP2 ADCs for Metastatic NSCLC: Setting the Stage for Future Use
TROP2 ADCs for Metastatic NSCLC: Setting the Stage for Future Use
CME/CE
TROP2 ADCs for Metastatic NSCLC: Setting the Stage for Future Use
- Benjamin Levy, MD
- Rebecca Heist, MD, MPH
- Peter Bela Illei, MD

Previous
1
2
…
5
6
7
Next

7/6